Carcinoma, Renal Cell
Showing 51 - 75 of 185
Carcinoma, Renal Cell Trial in Philadelphia (Pazopanib, DCE-MRI and Quantitative Doppler Ultrasound)
Completed
- Carcinoma, Renal Cell
- Pazopanib
- DCE-MRI and Quantitative Doppler Ultrasound
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Mar 25, 2020
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)
Completed
- Lymphoma, Non-Hodgkin
- +6 more
-
Duarte, California
- +41 more
Mar 4, 2020
KIDSTAGE- Staging of Kidney Cancer Using Dual Time PET/CT and
Completed
- Carcinoma, Renal Cell
-
Odense C, Odense, DenmarkOdense University Hospital
Mar 3, 2020
Kidney Tumors, Carcinoma, Renal Cell Trial in Bordeaux (Anxiety, renal anatomy and surgery questionnaires)
Withdrawn
- Kidney Neoplasms
- Carcinoma, Renal Cell
- Anxiety, renal anatomy and surgery questionnaires
-
Bordeaux, FranceCHU de Bordeaux
Jan 22, 2020
Carcinoma, Renal Cell, Prostatic Tumors Trial in United Kingdom, United States (FK228 (romidepsin))
Completed
- Carcinoma, Renal Cell
- Prostatic Neoplasms
- FK228 (romidepsin)
-
Duarte, California
- +4 more
Nov 14, 2019
Melanoma, Carcinoma, Renal Cell Trial run by the NCI (rh IL-15)
Completed
- Melanoma
- Carcinoma, Renal Cell
- rh IL-15
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 7, 2019
Carcinoma, Renal Cell, Clear Cell Renal Cell Carcinoma Trial in Russian Federation (axitinib)
Completed
- Carcinoma, Renal Cell
- Clear Cell Renal Cell Carcinoma
-
Irkutsk, Russian Federation
- +14 more
Oct 18, 2019
Carcinoma, Renal Cell, Tumor Metastasis Trial in Duarte, Chicago, Seattle (FK228 (romidepsin))
Completed
- Carcinoma, Renal Cell
- Neoplasm Metastasis
- FK228 (romidepsin)
-
Duarte, California
- +2 more
Oct 16, 2019
Carcinoma, Renal Cell Trial in Australia, Korea, Republic of (Pazopanib followed by everolimus)
Terminated
- Carcinoma, Renal Cell
- Pazopanib followed by everolimus
-
Garran, Australian Capital Territory, Australia
- +14 more
Sep 20, 2019
NSCLC, Carcinoma, Renal Cell, Melanoma Trial in Singapore (rSIFN-co)
Completed
- Carcinoma, Non-Small-Cell Lung
- +4 more
-
Singapore, SingaporeNational Cancer Centre Singapore
Sep 25, 2019
Response to Systemic Treatments in Renal Cell Cancer
Unknown status
- Carcinoma, Renal Cell
- Laboratory analysis of samples
- Application of machine learning
- (no location specified)
Aug 16, 2019
NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)
Terminated
- Carcinoma, Non-Small-Cell Lung
- +7 more
-
Birmingham, Alabama
- +10 more
Jul 17, 2019
Carcinoma, Renal Cell, Melanoma Trial in Charlottesville (Pembrolizumab, Interleukin-2)
Withdrawn
- Carcinoma, Renal Cell
- Melanoma
-
Charlottesville, VirginiaUniversity of Virginia Cancer Center
Jul 9, 2019
Metastatic Renal Cell Carcinoma Who Have Progressed After
Withdrawn
- Carcinoma, Renal Cell
- Not applicable - blood tests/tissue specimen tests will be undertaken
-
Kelowna, British Columbia, Canada
- +2 more
Jul 9, 2019
Carcinoma, Renal Cell Trial in Ann Arbor (Pazopanib, Low Fat Diet)
Completed
- Carcinoma, Renal Cell
- Pazopanib
- Low Fat Diet
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Mar 8, 2019
Advanced Renal Cell Carcinoma, With Failure or Unsuitable on
Terminated
- Carcinoma, Renal Cell
- Sorafenib (Nexavar, BAY43-9006)
- (no location specified)
Jun 2, 2019
Carcinoma, Renal Cell Trial in Indianapolis (Sonatherm 600i ablation system)
Completed
- Carcinoma, Renal Cell
- Sonatherm 600i ablation system
-
Indianapolis, IndianaIU Health University Hospital
Mar 21, 2019
Follow up After Cryoablation of Small Renal Masses.
Completed
- Carcinoma, Renal Cell
- 111In-Girentuximab DOTA SPECT
-
Nijmegen, NetherlandsRadboud University Medical Center
Jan 9, 2019
Carcinoma, Renal Cell, Vaccination, Secondary Trial in Meldola (FC) (radiation, biological, drug)
Withdrawn
- Carcinoma, Renal Cell
- +2 more
- boost radiotherapy (XRT)
- +2 more
-
Meldola (FC), FC, ItalyUO Immunoterapia e Laboratorio TCS, IRCCS IRST
Nov 8, 2018
Carcinoma, Renal Cell Trial in Houston (Sunitinib, Temsirolimus, Sorafenib)
Terminated
- Carcinoma, Renal Cell
- Sunitinib
- +5 more
-
Houston, TexasUTHealth Memorial Hermann Cancer Center
Sep 12, 2018
Advanced Renal Cell Carcinoma
Unknown status
- Carcinoma, Renal Cell
-
Göteborg, SwedenSahlgrenska University Hospital
Oct 8, 2018